Attovia Therapeutics, Inc. IPO Research Information

Attovia Therapeutics, Inc. IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on Attovia Therapeutics, Inc. , and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
Attovia Therapeutics, Inc.	ATTO - NASDAQ	$17.00-$17.00	$17.00	$21.00	17 million	8/5/2026
Underwriter(s): Morgan Stanley, Leerink Partners, Citigroup, RBC Capital Markets, LifeSci Capital
Co-Manager(s):
Industry: Health Care
Filing(s): Filed 2026-07-14 Terms Added 2026-07-29 Amended Terms 2026-08-04 Amended Terms 2026-08-04

Attovia Therapeutics, Inc. Quote & Chart - Click for current quote - ATTO

About Attovia Therapeutics, Inc. (adapted from Attovia Therapeutics, Inc. prospectus):
They are a clinical-stage biopharmaceutical company developing next-generation biotherapeutics for immune-mediated diseases with high unmet need.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as "ATTO" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.